Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease

被引：0
|
作者：
Audrey Benyamine
Xavier Heim
Noémie Resseguier
Daniel Bertin
Carine Gomez
Mikaël Ebbo
Jean-Robert Harlé
Gilles Kaplanski
Pascal Rossi
Nathalie Bardin
Brigitte Granel
机构：
[1] APHM,CHU Nord, Internal Medicine Department, North hospital of Marseilles
[2] Aix Marseille Univ,CHU Conception, Immunology Laboratory
[3] INSERM,CHU Timone, Epidemiology and Health Economics Unit
[4] INRA,CHU Nord, Pneumology Department
[5] C2VN,CHU Timone, Internal Medicine Department
[6] APHM,CHU Conception, Internal Medicine Department
[7] APHM,undefined
[8] Aix-Marseille University (AMU),undefined
[9] Faculty of Medicine,undefined
[10] APHM,undefined
[11] APHM,undefined
[12] APHM,undefined
来源：
Rheumatology International | 2018年 / 38卷
关键词：
Krebs von den Lungen-6; Systemic sclerosis; Lung fibrosis; Disease severity; Anti-topoisomerase 1 antibody (Scl70);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：813 / 819
页数：6
相关论文
共 50 条
  • [1] Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
    Benyamine, Audrey
    Heim, Xavier
    Resseguier, Noemie
    Bertin, Daniel
    Gomez, Carine
    Ebbo, Mikael
    Harle, Jean-Robert
    Kaplanski, Gilles
    Rossi, Pascal
    Bardin, Nathalie
    Granel, Brigitte
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (05) : 813 - 819
  • [2] Significance of serum Krebs von den Lungen-6 in systemic sclerosis
    Noha Hosni Ibrahim
    Yasser Abd-Elaziz Abd-Elhamid
    Refaat Mostafa El Tanawy
    Rasha Abdel Hameed
    Hanaa Alaa Mahmoud Elbastawesy
    Egyptian Rheumatology and Rehabilitation, 50
  • [3] Significance of serum Krebs von den Lungen-6 in systemic sclerosis
    Ibrahim, Noha Hosni
    Abd-Elhamid, Yasser Abd-Elaziz
    El Tanawy, Refaat Mostafa
    Hameed, Rasha Abdel
    Elbastawesy, Hanaa Alaa Mahmoud
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2023, 50 (01)
  • [4] Seasonal fluctuation of serum Krebs von den Lungen-6 levels in systemic sclerosis-associated interstitial lung disease
    Hirose, Hikaru
    Higuchi, Tomoaki
    Takagi, Kae
    Tochimoto, Akiko
    Ichimura, Yuki
    Harigai, Masayoshi
    Kawaguchi, Yasushi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (07)
  • [5] Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease
    Kuwana, Masataka
    Shirai, Yuichiro
    Takeuchi, Tsutomu
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (10) : 1825 - 1831
  • [6] Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease
    Ko, Ui Won
    Cho, Eun Jung
    Oh, Heung-Bum
    Koo, Hyun Jung
    Do, Kyung-Hyun
    Song, Jin Woo
    PLOS ONE, 2020, 15 (12):
  • [7] Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis
    Chung, Chiwook
    Kim, Jiwon
    Cho, Hyo Sin
    Kim, Ho Cheol
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
    Ma, Hua
    Lu, Junhui
    Song, Yuanyuan
    Wang, Huixuan
    Yin, Songlou
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [9] The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
    Hua Ma
    Junhui Lu
    Yuanyuan Song
    Huixuan Wang
    Songlou Yin
    BMC Pulmonary Medicine, 20
  • [10] Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis
    Chiwook Chung
    Jiwon Kim
    Hyo Sin Cho
    Ho Cheol Kim
    Scientific Reports, 12
12345